57 results
8-K
EX-99.1
NTRA
Natera, Inc.
8 Aug 24
Natera Reports Second Quarter 2024 Financial Results
4:11pm
with cutting-edge science, an innovative product portfolio, and excellent service that is core to our mission.”
Second Quarter Ended June 30, 2024
8-K
EX-99.1
NTRA
Natera, Inc.
9 May 24
Natera Reports First Quarter 2024 Financial Results
4:13pm
breakeven earlier than expected,” said Steve Chapman, chief executive officer of Natera. “We continued to deliver on our mission to transform disease
8-K
EX-99.1
NTRA
Natera, Inc.
9 May 23
Natera Reports First Quarter 2023 Financial Results
4:01pm
of additional patients and advancing our mission to transform the management of disease.”
First Quarter Ended March 31, 2023 Financial Results
Total
POSASR
70j5847b7tvazn
6 Dec 22
Automatic shelf registration (post-effective amendment)
4:06pm
S-3ASR
uwdanyylcu
10 Sep 21
Automatic shelf registration
9:13am
8-K
EX-99.1
h0hcnfsxt maao41a5ti
5 Aug 21
Natera Reports Second Quarter
4:10pm
8-K
EX-99.2
ji76om3at
22 Jul 21
Natera Launches Proposed Follow-On Offering
5:20pm
8-K
EX-99.1
7asym 0pkr
22 Jul 21
Natera Launches Proposed Follow-On Offering
5:20pm
8-K
EX-99.1
xkscq2n azuub4l
20 Jul 21
Natera Reports Preliminary Second Quarter 2021 Results
4:29pm
8-K
EX-99.1
4vnspau4ua
6 May 21
Natera Reports First Quarter 2021 Financial Results
4:08pm
8-K
EX-99.1
8yzfeo36gnb9v3 5ne
25 Feb 21
Natera Reports Fourth Quarter and Year 2020 Financial Results
4:10pm
8-K
EX-99.1
m168pme lw7wm7
23 Nov 20
Natera Appoints Dr. Monica Bertagnolli to its Board of Directors
5:04pm
8-K
EX-99.1
xfikcrgis
5 Nov 20
Natera Reports Third Quarter 2020 Financial Results
4:24pm
8-K
EX-99.2
djey7ovuvno zvy9
11 Sep 20
Natera Launches Proposed Follow-On Offering
4:28pm